New Classifications of Five Distinct “Sleep” Profi... ...
A Professional Overview of Hypertension ...
High-speed imaging tracks live brain cell activity...
Drug candidate slows motor neuron disease progress...
Drug candidate slows motor neuron disease progress...
Mark Cuban: A Master Disrupter for American Health...
Superbugs on your plate: How antimicrobial resistance spread...
June 13,2026
Can marijuana cause lung cancer?...
June 12,2026
Standard depression screening could be missing key symptoms ...
June 11,2026
More women are having babies later in life. How to improve y...
June 10,2026
For severe babesiosis, red blood cell exchange is associated...
June 09,2026
Cause or effect? Study answers question about gene linked wi...
June 08,2026
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Today's News
Eye Infections (Updated) | Clinical Medicine...
Announcement of the 2025 Nobel Prize in ...
Dr. Fauci among hundreds who've contract...
Why are young, healthy adults experienci...
Reprogramming Stem Cells Could Cure Type...
More News
Novel mechanism supports antitumor response and T-cell survival

Novel mechanism supports antitumor response and T-cell survival

by Melissa Rohman,Northwestern UniversityRepresentative composite image of a breast cancer specimen stained by multi-color IHC comprising CD8, Ki67, GCLC, GPX4, 923 A2AR, PanCK and DAPI. Represe
Oncology April 30,2024
Novel mechanism supports antitumor response and T-cell survival

Novel mechanism supports antitumor response and T-cell survival

by Melissa Rohman,Northwestern UniversityRepresentative composite image of a breast cancer specimen stained by multi-color IHC comprising CD8, Ki67, GCLC, GPX4, 923 A2AR, PanCK and DAPI. Represe
Oncology April 30,2024
Artificial intelligence analysis of DNA fragmentomes and protein biomarkers noninvasively detects ovarian cancer

Artificial intelligence analysis of DNA fragmentomes and protein biomarkers noninvasively detects ovarian cancer

byAmerican Association for Cancer ResearchCredit: Unsplash/CC0 Public DomainA blood-based machine learning assay that combines cell-free DNA (cfDNA) fragment patterns and levels of the proteins
Oncology April 30,2024
Artificial intelligence analysis of DNA fragmentomes and protein biomarkers noninvasively detects ovarian cancer

Artificial intelligence analysis of DNA fragmentomes and protein biomarkers noninvasively detects ovarian cancer

byAmerican Association for Cancer ResearchCredit: Unsplash/CC0 Public DomainA blood-based machine learning assay that combines cell-free DNA (cfDNA) fragment patterns and levels of the proteins
Oncology April 30,2024
CAR T cell therapy targeting HER2 antigen shows promise against advanced sarcoma in clinical trial

CAR T cell therapy targeting HER2 antigen shows promise against advanced sarcoma in clinical trial

byBaylor College of MedicineCredit: Pixabay/CC0 Public DomainResearchers at Texas Children's Cancer Center and the Center for Cell and Gene Therapy at Baylor College of Medicine, Texas Child
Oncology April 30,2024
CAR T cell therapy targeting HER2 antigen shows promise against advanced sarcoma in clinical trial

CAR T cell therapy targeting HER2 antigen shows promise against advanced sarcoma in clinical trial

byBaylor College of MedicineCredit: Pixabay/CC0 Public DomainResearchers at Texas Children's Cancer Center and the Center for Cell and Gene Therapy at Baylor College of Medicine, Texas Child
Oncology April 30,2024
Researchers discover cell 'crosstalk' that triggers cancer cachexia

Researchers discover cell 'crosstalk' that triggers cancer cachexia

byUniversity of OklahomaGraphical abstract. Credit:Cancer Cell(2024). DOI: 10.1016/j.ccell.2024.03.009New research from the University of Oklahoma reveals a previously unknown chain
Oncology April 30,2024
Researchers discover cell 'crosstalk' that triggers cancer cachexia

Researchers discover cell 'crosstalk' that triggers cancer cachexia

byUniversity of OklahomaGraphical abstract. Credit:Cancer Cell(2024). DOI: 10.1016/j.ccell.2024.03.009New research from the University of Oklahoma reveals a previously unknown chain
Oncology April 30,2024
Survivorship portal brings cancer researchers one click away from discovery

Survivorship portal brings cancer researchers one click away from discovery

bySt. Jude Children's Research HospitalCredit: Pixabay/CC0 Public DomainScientists from St. Jude Children's Research Hospital today announced the St. Judesurvivorship portal—the fi
Oncology April 30,2024
Survivorship portal brings cancer researchers one click away from discovery

Survivorship portal brings cancer researchers one click away from discovery

bySt. Jude Children's Research HospitalCredit: Pixabay/CC0 Public DomainScientists from St. Jude Children's Research Hospital today announced the St. Judesurvivorship portal—the fi
Oncology April 30,2024
Colorless, odorless gas likely linked to alarming rise in non-smoking lung cancer

Colorless, odorless gas likely linked to alarming rise in non-smoking lung cancer

byOhio State University Medical CenterExperts say the only way to know if there are high levels of radon in your home is to test for it. Radon is the leading cause of lung cancer among non-smoke
Oncology April 30,2024
Colorless, odorless gas likely linked to alarming rise in non-smoking lung cancer

Colorless, odorless gas likely linked to alarming rise in non-smoking lung cancer

byOhio State University Medical CenterExperts say the only way to know if there are high levels of radon in your home is to test for it. Radon is the leading cause of lung cancer among non-smoke
Oncology April 30,2024
More than 25% of cancer survivors report significant levels of disability after cancer diagnosis, according to new study

More than 25% of cancer survivors report significant levels of disability after cancer diagnosis, according to new study

byDana-Farber Cancer InstituteCredit: Unsplash/CC0 Public DomainA survey of nearly 50,000 cancer survivors has found that more than a quarter had a physical disability that impaired their mobili
Oncology April 30,2024
More than 25% of cancer survivors report significant levels of disability after cancer diagnosis, according to new study

More than 25% of cancer survivors report significant levels of disability after cancer diagnosis, according to new study

byDana-Farber Cancer InstituteCredit: Unsplash/CC0 Public DomainA survey of nearly 50,000 cancer survivors has found that more than a quarter had a physical disability that impaired their mobili
Oncology April 30,2024
Extracellular cell matrix stiffness may induce drug resistance of breast cancer cells

Extracellular cell matrix stiffness may induce drug resistance of breast cancer cells

by Shanghai Jiao Tong University Journal CenterCredit:Mechanobiology in Medicine(2023). DOI: 10.1016/j.mbm.2023.100023A new study, led by Prof. Liu from the department of pharmacy, Univers
Oncology April 30,2024
Extracellular cell matrix stiffness may induce drug resistance of breast cancer cells

Extracellular cell matrix stiffness may induce drug resistance of breast cancer cells

by Shanghai Jiao Tong University Journal CenterCredit:Mechanobiology in Medicine(2023). DOI: 10.1016/j.mbm.2023.100023A new study, led by Prof. Liu from the department of pharmacy, Univers
Oncology April 30,2024
Exploring the role of artificial intelligence in early cancer detection

Exploring the role of artificial intelligence in early cancer detection

by Kathryn Ryan,Mary Ann Liebert, IncCredit: AI-generated imageTwo new review articles inAI in Precision Oncologyexplore the role of artificial intelligence (AI) in early cancer dete
Oncology April 30,2024
Exploring the role of artificial intelligence in early cancer detection

Exploring the role of artificial intelligence in early cancer detection

by Kathryn Ryan,Mary Ann Liebert, IncCredit: AI-generated imageTwo new review articles inAI in Precision Oncologyexplore the role of artificial intelligence (AI) in early cancer dete
Oncology April 30,2024
Researchers review use of MRI to identify brain cancer biomarkers

Researchers review use of MRI to identify brain cancer biomarkers

byKing's College LondonCredit: Pixabay/CC0 Public DomainResearchers from the School of Biomedical Engineering & Imaging Sciences (BMEIS) have published asystematic reviewin&n
Oncology April 30,2024
Researchers review use of MRI to identify brain cancer biomarkers

Researchers review use of MRI to identify brain cancer biomarkers

byKing's College LondonCredit: Pixabay/CC0 Public DomainResearchers from the School of Biomedical Engineering & Imaging Sciences (BMEIS) have published asystematic reviewin&n
Oncology April 30,2024
More News
Week’s Top
Podcasts
... Preparing for a tough exam? A tough gym workout could help with your studies ... ... GOSH BRC Showcase 2025 - Genomic medicine ... ... Brain activity goes to extremes in soccer fans, neuroimaging reveals ...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com